1. Papadopoulos, MC, Verkman, AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol 2012; 11: 535–544. Google Scholar | Crossref | Medline | ISI 2. Lee, EJ, Lim, YM, Kim, SY, et al. The clinical and prognostic value of antinuclear antibodies in NMO-IgG seropositive neuromyelitis optica spectrum disorder. J Neuroimmunol 2019; 328: 1–4. Google Scholar | Crossref | Medline 3. Fujihara, K. Neuromyelitis optica spectrum disorders: Still evolving and broadening. Curr Opin Neurol 2019; 32(3): 385–394.